BLA 103158, held by Interferon Sciences. Interferon Alfa-N3.
As of Nov 13, 2026, BLA 103158 (Alferon N Injection), held by Interferon Sciences, was first approved by FDA on Oct 10, 1989, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 10, 1989 | Original applicationNew molecular entity | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Alferon N Injection5MIU/VIAL ยท vial | Interferon Alfa-N3 | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed weekly; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
